Challenges facing an outsourcing dialysis program amid the COVID-19 pandemic: Diaverum AB experience
DOI:
https://doi.org/10.3396/ijic.v17.20619Keywords:
COVID-19, coronavirus, renal dialysis, infection control, pandemics, Saudi ArabiaAbstract
Coronavirus disease 2019 (COVID-19), a disease caused by a novel coronavirus, is a major global human threat that has turned into a pandemic. Elderly patients and patients with comorbid conditions have a higher risk of complications and morbidity. Patients suffering from kidney disease on hemodialysis have an intrinsic fragility combined with a frequent burden of comorbidities in hemodialysis centers, a setting in which many patients are repeatedly treated in the same area. Moreover, if infected, the intensity of dialysis requiring specialized resources and staff is further complicated by requirements for isolation, control and prevention, putting healthcare systems under additional and exceptional strain. Therefore, all measures to slow if not eradicate the pandemic and to control unmanageably high incidence rates must be taken very seriously. Diaverum is a renal health services company playing a major role in providing end-stage kidney disease (ESKD) patients with optimum dialysis services. The aim of the present review is to shed light on the challenges and steps taken by an outsourcing dialysis program to provide recommendations for the prevention, mitigation, and containment of the emerging COVID-19 pandemic in hemodialysis centers.
Downloads
References
Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A. World Health Organization declares global emergency. A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71–76. doi: 10.1016/j.ijsu.2020.02.034
Kliger AS, Cozzolino M, Jha V, et al. Managing the COVID-19 pandemic: international comparisons in dialysis patients. Kidney Int 2020; 98: 12–16. doi: 10.1016/j.kint.2020.04.007
Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis 2019; 26: 8–15. doi: 10.1053/j.ackd.2019.01.004
Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol 2013; 9: 255–65. doi: 10.1038/nrneph.2013.44
Dudreuilh C, Kumar N, Moxham V, et al. De-isolation of COVID-19–positive hemodialysis patients in the outpatient setting: a single-center experience. Kidney Int 2020; 98: 228–239. doi: 10.1016/j.kint.2020.04.021
Centers for Disease Control and Prevention. Interim additional guidance for infection prevention and control recommendations for patients with suspected or confirmed COVID-19 in outpatient hemodialysis facilities, 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/dialysis.html [cited 19 March 2020].
Temsah M, Al-Sohime F, Alamro N, et al. The psychological impact of COVID-19 pandemic on health care workers in a MERS-CoV endemic country. J Infect Public Health 2020; 13: 877–82. doi: 10.1016/j.jiph.2020.05.021
Alberici F, Delbarba E, Manenti C, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV2 infection. Kidney Int 2020; 98: 20–26. doi: 10.1016/j.kint.2020.04.030
Goicoechea M, Sánchez Cámara LA, Macías N, et al. COVID-19: clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain. Kidney Int 2020; 98: 27–34. doi: 10.1016/j.kint.2020.04.031
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323(20): 2052–2059. doi: 10.1001/jama.2020.6775
Published
How to Cite
Issue
Section
License
Authors retain copyright of their work, with first publication rights granted to IJIC. Read the full Copyright- and Licensing Statement.
